BCL2 and breast carcinoma: Amygdalin (5–20 mg mL−1) may trigger apoptosis in a concentration-dependent manner by increasing pro-apoptotic Bax protein and decreasing anti-apoptotic Bcl-2 protein in SK-BR-3 cells (HER2 overexpressing human breast cancer cell line) [95].